Nanomicrobe seeks active Industrial and academic partners to develop its Nano drug delivery technology and Antimicrobial to clinics. Please write to use to explore collaboration opportunities.

Nanomicrobe also seeks commercial partner to commercialise its drug delivery technology for both research and in-vivo use. Our CarboPlus transfection reagent is optimised for transfecting 293t cells. Please write to us if you want to distribute our technology.